Cox regression models ( excluding participants reporting preexisting peripheral neuropathy at ART initiation ) , considered sex ; pre-ART WHO stage , age and CD4 ( + ) cell count ; CD4 ( + ) cell count versus no CD4 ( + ) cell count monitoring ; and time-updated CD4 ( + ) cell count , weight and use of stavudine , isoniazid and didanosine .